Risk factors for malignant ventricular arrhythmias in lamin A/C mutation carriers: a European cohort study. J Am Coll Cardiol. 2012;59:493 500. S7.3-45. Cox MG, van der Zwaag PA, van der Werf C, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmo- some mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/car- diomyopathy genotype-phenotype follow-up study. Circulation. 2011;123:2690 700. S7.3-46. Saeed M, Homoud MK, Wang PJ, et al. Role of invasive electro- physiologic testing in risk stratification for sudden cardiac death. J Invasive Cardiol. 2001;13:758 62. S7.3-47. Zhu DW, Sun H, Hill R, et al. The value of electrophysiology study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol. 1998;21:299 302. S7.3-48. Wichter T, Borggrefe M, Haverkamp W, et al. Efficacy of antiarrhyth- mic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation. 1992;86:29 37. CLINICAL STATEMENTS AND GUIDELINES 7.4. Hypertrophic Cardiomyopathy S7.4-1. Elliott PM, Sharma S, Varnava A, et al. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1999;33:1596 601. S7.4-2. Elliott PM, Poloniecki J, Dickie S, et al. Sudden death in hypertro- phic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol. 2000;36:2212 8. S7.4-3. Elliott PM, Gimeno Blanes JR, Mahon NG, et al. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet. 2001;357:420 4. S7.4-4. Elliott PM, Gimeno JR, Tome MT, et al. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic car- diomyopathy. Eur Heart J. 2006;27:1933 41. S7.4-5. Maki S, Ikeda H, Muro A, et al. Predictors of sudden cardiac death in hypertrophic cardiomyopathy. Am J Cardiol. 1998;82:774 8. S7.4-6. Maron BJ, Spirito P, Shen WK, et al. 